Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 49 (RPL21P49)

Target: RPL21P49
Molecular classification: Pseudogene, Non-coding RNA (potential regulatory role)

Overview

RPL21P49 is a pseudogene, specifically ribosomal protein L21 pseudogene 49. It is a DNA sequence that shares high similarity with the functional ribosomal protein L21 (RPL21) gene but has accumulated mutations that prevent it from being translated into a functional protein. As a result, RPL21P49 is generally considered non-functional in terms of protein production. While some pseudogenes have been found to exert non-coding regulatory functions, such as influencing the expression of their parent genes or acting as miRNA sponges, specific and well-defined biological roles for RPL21P49 are not broadly established. Due to its nature as a non-coding pseudogene, it is not typically considered a direct therapeutic target for drug development.

Other names: Pseudogene of RPL21

Mechanism of action

N/A (not a drug target)

Biological functions

Loss of protein-coding abilityDerived from ribosomal protein L21 genePotential regulatory roles through non-coding mechanisms (e.g., affecting parent gene expression, miRNA sponging), though specific functions for RPL21P49 are not well-defined.

Disease associations

Not typically a primary disease driver due to its non-coding nature.Potential involvement in disease states if its regulatory functions are disrupted, but direct roles are generally unconfirmed or subtle.

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 49 (RPL21P49).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 49 (RPL21P49).

Explore the full profile